The effect of infections on the mortality of cirrhotic patients with hepatic encephalopathy

Epidemiology and Infection

Volumn 141, Issue 12, 2013, Pages 2671-2678

  Hung, T H ^a,b   Lay, C J ^a,b   Chang, C M ^a,b   Tsai, J J ^c   Tsai, C C ^a,b,d  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAMKANG UNIVERSITY   (Taiwan)

Author keywords

Cirrhosis; hepatic encephalopathy; pneumonia; spontaneous bacterial peritonitis; urinary tract infection

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BILIARY TRACT INFECTION; CELLULITIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH INSURANCE; PNEUMONIA; POPULATION RESEARCH; PROGNOSIS; RETROSPECTIVE STUDY; SEPSIS; SEX DIFFERENCE; TAIWAN; URINARY TRACT INFECTION;

EID: 84893040138     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813000186     Document Type: Article

References (32)

1. Häussinger D, et al. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008; 57: 1156-1165.
2. Shawcross DL, et al. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. Journal of Hepatology 2011; 54: 640-649.
3. Shawcross DL, et al. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metabolic Brain Disease 2007; 22: 125-138.
4. Wright G, et al. Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box Hepatology 2007; 46: 291-294.
5. Bajaj JS, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010; 138: 2332-2340.
6. Muto Y, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clinical Gastroenterology and Hepatology 2005; 3: 705-713.
7. Michitaka K, et al. (2008) Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatology Research 2008; 38: 1069-1075.
8. Li YY, et al. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World Journal of Gastroenterology 2004; 10: 2397-2401.
9. Wong F, et al. Sepsis in cirrhosis: Report on the 7th meeting of the International Ascites Club. Gut 2005; 54: 718-725.
10. Borzio M, et al. Bacterial infection in patients with advanced cirrhosis: A multicentre prospective study. Digestive and Liver Disease 2001; 33: 41-48.
11. Gustot T, et al. Severe sepsis in cirrhosis. Hepatology 2009; 50: 2022-2033.
12. Arroyo V, et al. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. Journal of Hepatology 2000; 32: 157-170.
13. Arvaniti V, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010; 139: 1246-1256.
14. Jones EA, et al. Theories of the pathogenesis of hepatic encephalopathy. Clinical Liver Disease 2012; 16: 7-26.
15. Strauss E, et al. Bacterial infections associated with hepatic encephalopathy: Prevalence and outcome. Annual of Hepatology 2003; 2: 41-45.
16. Restrepo MI, et al. Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest 2010; 137: 552-557.
17. Martin GS, et al. The epidemiology of sepsis in the United States from 1979 through 2000. New England Journal of Medicine 2003; 348: 1546-1554.
18. Chen CC, et al. Non-adherence to antibiotic prescription guidelines in treating urinary tract infection of children: A population-based study in Taiwan. Journal of Evaluation of Clinical Practice 2011; 17: 1030-1035.
19. Thuluvath PJ, et al. Spontaneous bacterial peritonitis - in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. American Journal of Gastroenterology 2001; 96: 1232-1236.
20. Navasa M, et al. Bacterial infections in liver cirrhosis. Italian Journal of Gastroenterology and Hepatology 1999; 31: 616-625.
21. Marik PE. Aspiration pneumonitis and aspiration pneumonia. New England Journal of Medicine 2001; 344: 665-671.
22. Kennedy TP, et al. Acute acid aspiration lung injury in the rat: Biphasic pathogenesis. Anesthesia and Analgesia 1989; 69: 87-92.
23. Knight PR, et al. The role of neutrophils, oxidants, and proteases in the pathogenesis of acid pulmonary injury. Anesthesiology 1992; 77: 772-778.
24. Nemzek JA, et al. Functional contribution of CXCR2 to lung injury after aspiration of acid and gastric particulates. American Journal of Physiology - Lung Cellular and Molecular Physiology 2010; 298: L382-391.
25. Pawlik MT, et al. Hydrochloric acid aspiration increases right ventricular systolic pressure in rats. European Journal of Anaesthesiology 2009; 26: 285-292.
26. Amigoni M, et al. Lung injury and recovery in a murine model of unilateral acid aspiration: Functional, biochemical, and morphologic characterization. Anesthesiology 2008; 108: 1037-1046.
27. Lipcsey M, et al. Septic acute kidney injury: Hemodynamic syndrome, inflammatory disorder, or both Critical Care 2011; 15: 1008.
28. Kim WY, et al. Analysis of progression in risk, injury, failure, loss, and end-stage renal disease classification on outcome in patients with severe sepsis and septic shock. Journal of Critical Care 2012; 27: 104.e1-7.
29. Riggio O, et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene- covered stent grafts. American Journal of Gastroenterology 2008; 103: 2738-2746.
30. Guevara M, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: Relevance of serum sodium concentration. Liver International 2010; 30: 1137-1142.
31. Udayakumar N, et al. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: A preliminary observation. Journal of Clinical Gastroenterology 2007; 41: 922-926.
32. Hsu HC, et al. Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells. Cancer 1983; 52: 1825-1832.